C-peptide promotes lesion development in a mouse model of arteriosclerosis

Journal of Cellular and Molecular Medicine

Volumn 16, Issue 4, 2012, Pages 927-935

  Vasic, Dusica ^a   Marx, Nikolaus ^b   Sukhova, Galina ^c   Bach, Helga ^a   Durst, Renate ^a   Grüb, Miriam ^a   Hausauer, Angelina ^a   Hombach, Vinzenz ^a   Rottbauer, Wolfgang ^a   Walcher, Daniel ^a  

^a UNIVERSITY OF ULM   (Germany)

^b UNIVERSITY HOSPITAL RWTH AACHEN   (Germany)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

ApoE deficient mice; Atherosclerosis; C peptide

Indexed keywords

MUS;

APOLIPOPROTEIN E; C PEPTIDE;

AMINO ACID SEQUENCE; ANIMAL; ARTERIOSCLEROSIS; ARTICLE; DISEASE MODEL; GENETICS; IN VITRO STUDY; MACROPHAGE; METABOLISM; MOLECULAR GENETICS; MOUSE; MOUSE MUTANT; PATHOLOGY; PHYSIOLOGY;

AMINO ACID SEQUENCE; ANIMALS; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; C-PEPTIDE; DISEASE MODELS, ANIMAL; MACROPHAGES; MICE; MICE, KNOCKOUT; MOLECULAR SEQUENCE DATA;

EID: 84867851421     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1582-4934.2011.01365.x     Document Type: Article

References (22)

1. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999; 340: 115-26.
2. Hansson GK. Inflammation, atherosclerosis, and coronary artery disease. N Engl J Med. 2005; 352: 1685-95.
3. Wahren J, Ekberg K, Jörnvall H. C-peptide is a bioactive peptide. Diabetologia 2007; 50: 503-9.
4. Wahren J, Shafqat J, Johansson J, et al. Molecular and cellular effects of C-peptidenew perspectives on an old peptide. Exp Diabesity Res. 2004; 5: 15-23.
5. Kitamura T, Kimura K, Jung BD, et al. Proinsulin C-peptide rapidly stimulates mitogen-activated protein kinases in Swiss 3T3 fibroblasts: requirement of protein kinase C, phosphoinositide 3-kinase and pertussis toxin-sensitive G-protein. Biochem J. 2001; 355: 123-9.
6. Kitamura T, Kimura K, Jung BD, et al. Proinsulin C-peptide activates cAMP response element-binding proteins through the p38 mitogen-activated protein kinase pathway in mouse lung capillary endothelial cells. Biochem J. 2002; 366: 737-44.
7. Marx N, Walcher D, Raichle C, et al. Cpeptide colocalizes with macrophages in early arteriosclerotic lesions of diabetic subjects and induces monocyte chemotaxis in vitro. Arterioscler Thromb Vasc Biol. 2004; 24: 540-5.
8. Walcher D, Aleksic M, Jerg V, et al. Cpeptide induces chemotaxis of human CD4-positive cells: involvement of pertussis toxin-sensitive G-proteins and phosphoinositide 3-kinase. Diabetes 2004; 53: 1664-70.
9. Aleksic M, Walcher D, Giehl K, et al. Signalling processes involved in C-peptide-induced chemotaxis of CD4-positive lymphocytes. Cell Molec Life Sci. 2009; 66: 1974-84.
10. Walcher D, Babiak C, Poletek P, et al. C-peptide induces vascular smooth muscle cell proliferation: involvement of SRC-kinase, phosphatidylinositol 3-kinase, and extracellular signal-regulated kinase 1/2. Circ Res. 2006; 99: 1181-7.
11. Gotsman I, Grabie N, Gupta R, et al. Impaired regulatory T cell response and enhanced atherosclerosis in the absence of inducible costimulatory molecule. Circulation 2006; 114: 2047-55.
12. Buono C, Pang H, Uchida Y, et al. B7-1/B7-2 co-stimulation regulates plaque antigen-specific T cell responses and atherogenesis in LDLR-deficient mice. Circulation 2004; 109: 2009-15.
13. Buono C, Binder CJ, Stavrakis G, et al. T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses. Proc Natl Acad Sci USA. 2005; 102: 1596-601.
14. Paigen B, Morrow A, Holmes PA, et al. Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis 1987; 68: 231-40.
15. Langer S, Born F, Breidenbach A, et al. Effect of C-peptide on wound healing and microcirculation in diabetic mice. Eur J Med Res. 2002; 25: 502-08.
16. Hills CE, Brunskill NJ. Cellular and physiological effects of C-peptide. Clin Sci. 2009; 116: 565-74.
17. An G, Miwa T, Song WL, et al. CD59 but not DAF deficiency accelerates atherosclerosis in female ApoE knockout mice. Mol Immunol. 2009; 46: 1702-9.
18. Veillard NR, Steffens S, Burger F, et al. Differential expression patterns of proinflammatory and antiinflammatory mediators during atherogenesis in mice. Arterioscler Thromb Vasc Biol. 2004; 24: 2339-44.
19. Cifarelli V, Luppi P, Tse HM, et al. Human proinsulin C-peptide reduces high glucose-induced proliferation and NF-kappaB activation in vascular smooth muscle cells. Atherosclerosis 2008; 201: 248-57.
20. Mughal RS, Scragg JL, Lister P, et al. Cellular mechanisms by which proinsulin C-peptide prevents insulin-induced neointima formation in human sphenous vein. Diabetologia 2010; 53: 1761-71.
21. Scalia R, Coyle KM, Levine BJ, et al. C-peptide inhibits leukocyteendothelium interaction in the microcirculation during acute endothelial dysfunction. FASEB J. 2000; 14: 2357-64.
22. Luppi P, Cifarelli V, Tse H, et al. Human C-peptide antagonises high glucoseinduced endothelial dysfunction through the nuclear factor-kappa B pathway. Diabetologia 2008; 51: 1534-43.